{"entity":{"id":"nct05717803","kind":"trial","name":"Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)","aka":[],"tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting.","summary":"Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) is a phase 3, interventional study registered as NCT05717803 by Fudan University, with a registry enrolment figure of 307 participants, started 2023-02-15 and due to reach its primary completion in 2028-12-31. Interventions recorded: Segmentectomy. Conditions listed: Segmentectomy; Lung Adenocarcinoma. Primary outcome: 5-year disease-free survival. Lung eligibility wording from the registry: \"* Not receiving lung cancer surgery before;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT05717803","url":"https://clinicaltrials.gov/study/NCT05717803"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05717803","phase":"3","setting":"Segmentectomy for Ground Glass-dominant Invasive Lung Cancer With Size of 2-3cm: a Single-arm, Multi-center, Phase III Trial","sponsor":"Fudan University","enrolled":307,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05717803/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}